Merck (MRK), Cubist (CBST) Deal Likely to Go Ahead Despite Unfavorable Litigation, Says RBC
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/15/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
- BOJ eyeing September rate hike, faster pace of tightening, sources say
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- SanDisk upgraded at JPMorgan after investor day; shares climb
- Micron: New Street upgrades to buy, says memory is no longer a cyclical story
Merck (MRK) on Watch as Takeover Target Cubist Pharma (CBST) Losses Patent Decision
December 8, 2014 5:20 PM ESTMerck (NYSE: MRK) is on watch on news today's takeover target Cubist Pharma (NASDAQ: CBST) lost a bid to prevent Hospira (NYSE: HSP) from making generic Cubicin.
Merck likely fully... More
Cubist Pharma (CBST) Declines: Traders Discuss Patent Dispute vs Hospira (HSP)
December 8, 2014 5:11 PM EST(Updated - December 8, 2014 5:21 PM EST)
Cubist Pharma (NASDAQ: CBST) declined after-hours Monday. Traders discussed comments from Evercore ISI related to a patent dispute with Hospira (NYSE: HSP). Below is a tweet from CNBC's Meg... More
